首页 › 股票 › NAMSW

NAMSW — NEWAMSTERDAM PHARMA COMPANY

申报持仓市值$32.15M
持有基金数(最新)24
板块材料

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)5
机构持仓市值$4.90M · 369.57K 股
新建/增持/减仓/清仓0 / 1 / 0 / 6 · 更新于 2026-11-16
前五大/前十大集中度100.0% / 100.0%
机构整体持仓变动 增持 +0.7% (+2.54K 股)
机构持仓市值变动 下降 -38.4%

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 5 家机构在其最新 13F 申报中持有 NAMSW(NEWAMSTERDAM PHARMA COMPANY),合计申报市值 $4.90M,对应 369.57K 股。按股数计算较上季度增持 0.7%(+2.54K 股),申报市值环比下降 38.4%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。

与上一季度相比,1 家加仓、6 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。

NEWAMSTERDAM PHARMA COMPANY(NAMSW)的主要机构持有人包括 Frazier Life Sciences Management, L.P.、RA CAPITAL MANAGEMENT, L.P.、Affinity Asset Advisors, LLC,按 13F 申报市值在本页 24 家持有人中排名居前。

NAMSW 属于Materials板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 5 369.57K $4.90M +0.7%
Q2 2026 11 1.46M $31.30M +0.9%
Q1 2026 11 1.45M $29.01M -0.2%
Q4 2025 10 1.45M $33.34M -0.0%
Q3 2025 10 1.45M $24.78M -0.0%
Q2 2025 11 1.45M $11.61M -0.4%
Q1 2025 11 1.46M $13.66M +0.0%
Q4 2024 12 1.47M $20.88M +0.8%

表内 8 个季度中,机构持股合计减少 75%(Q4 2024 → Q3 2026)。

前 25 大机构持仓人(Q3 2026) — 5 家基金

基金股数金额组合权重变化
Affinity Asset Advisors, LLC 245.00K $3.31M 0.15% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $1.26M 0.09% 持有
WOLVERINE ASSET MANAGEMENT LLC 17.46K $220.92K 0.00% 增持
Vestcor Inc 6.67K $103.00K 0.00% 持有
UBS Group AG 443 $5.75K 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 11 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 500.33K $10.69M 0.23% 持有
RA CAPITAL MANAGEMENT, L.P. 333.33K $7.12M 0.06% 持有
Affinity Asset Advisors, LLC 245.00K $5.34M 0.26% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $2.14M 0.13% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.98M 0.03% 持有
Millennium Management 75.00K $1.60M 0.00% 持有
MILLENNIUM MANAGEMENT LLC 75.00K $1.60M 0.00% 持有
ARISTEIA CAPITAL, L.L.C. 15.71K $343.38K 0.01% 持有
WOLVERINE ASSET MANAGEMENT LLC 14.93K $318.95K 0.01% 增持
Vestcor Inc 6.67K $143.00K 0.00% 持有
UBS Group AG 443 $8.52K 0.00% 增持

Q1 2026 — 11 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 500.33K $10.03M 0.26% 持有
RA CAPITAL MANAGEMENT, L.P. 333.33K $6.68M 0.07% 持有
Affinity Asset Advisors, LLC 245.00K $4.91M 0.26% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $2.00M 0.18% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.86M 0.03% 持有
Millennium Management 75.00K $1.50M 0.00% 持有
MILLENNIUM MANAGEMENT LLC 75.00K $1.50M 0.00% 持有
ARISTEIA CAPITAL, L.L.C. 15.71K $342.67K 0.01% 持有
Vestcor Inc 6.67K $131.00K 0.00% 减持
WOLVERINE ASSET MANAGEMENT LLC 2.13K $42.62K 0.00% 新进
UBS Group AG 396 $7.94K 0.00% 持有

Q4 2025 — 10 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 500.33K $11.51M 0.31% 持有
RA CAPITAL MANAGEMENT, L.P. 333.33K $7.67M 0.08% 持有
Affinity Asset Advisors, LLC 245.00K $5.63M 0.34% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $2.30M 0.18% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $2.13M 0.03% 持有
Millennium Management 75.00K $1.73M 0.00% 持有
MILLENNIUM MANAGEMENT LLC 75.00K $1.73M 0.00% 持有
ARISTEIA CAPITAL, L.L.C. 15.71K $397.02K 0.01% 新进
Vestcor Inc 9.63K $239.00K 0.01% 持有
UBS Group AG 396 $9.27K 0.00% 减持

Q3 2025 — 10 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 500.33K $8.56M 0.26% 持有
RA CAPITAL MANAGEMENT, L.P. 333.33K $5.70M 0.07% 持有
Affinity Asset Advisors, LLC 245.00K $4.19M 0.40% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $1.71M 0.11% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.59M 0.03% 持有
MILLENNIUM MANAGEMENT LLC 75.00K $1.28M 0.00% 持有
Millennium Management 75.00K $1.28M 0.00% 持有
Laurion Capital Management LP 16.67K $285.15K 0.01% 持有
Vestcor Inc 9.63K $165.00K 0.01% 持有
UBS Group AG 512 $8.76K 0.00% 减持

Q2 2025 — 11 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 500.33K $4.00M 0.16% 持有
RA CAPITAL MANAGEMENT, L.P. 333.33K $2.67M 0.04% 持有
Affinity Asset Advisors, LLC 245.00K $1.96M 0.30% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 100.00K $800.00K 0.10% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $742.30K 0.01% 持有
MILLENNIUM MANAGEMENT LLC 75.00K $600.00K 0.00% 持有
Millennium Management 75.00K $600.00K 0.00% 持有
Laurion Capital Management LP 16.67K $133.33K 0.01% 持有
Vestcor Inc 9.63K $77.00K 0.00% 持有
WOLVERINE ASSET MANAGEMENT LLC 2.09K $16.73K 0.00% 减持
UBS Group AG 993 $7.94K 0.00% 减持

新建仓(Q3 2026)

本季度没有基金新建该仓位。

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Affinity Asset Advisors, LLC 245.00K 245.00K 245.00K 245.00K 245.00K 245.00K 241.96K 237.94K 212.97K 202.60K 202.60K 137.00K 137.00K — — —
Bain Capital Life Sciences Investors, LLC 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K — — —
WOLVERINE ASSET MANAGEMENT LLC 17.46K 14.93K 2.13K — — 2.09K 8.88K 12.69K — — — — — — — —
Vestcor Inc 6.67K 6.67K 6.67K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K — — —
UBS Group AG 443 443 396 396 512 993 2.38K 2.48K — — — — 38 — — 1.08K
Frazier Life Sciences Management, L.P. — 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K — — —
RA CAPITAL MANAGEMENT, L.P. — 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K — — —
DEERFIELD MANAGEMENT COMPANY, L.P. — 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K — — —
Millennium Management — 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K
MILLENNIUM MANAGEMENT LLC — 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K — — —
GTS SECURITIES LLC — — — — — — — — — — 121.15K — — — — —
EcoR1 Capital, LLC — — — — — — — — — — — 66.67K 66.67K — — —
Ensign Peak Advisors, Inc — — — — — — — — — — — 150.00K 150.00K — — —
ARISTEIA CAPITAL, L.L.C. — 15.71K 15.71K 15.71K — — — — — — — — — — — —
Monashee Investment Management LLC — — — — — — — — 31.19K — 31.19K — — — — —
HRT FINANCIAL LP — — — — — — — 13.65K 27.12K 30.32K 30.32K 30.32K 30.32K — — —
Laurion Capital Management LP — — — — 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K — — —
ADAR1 Capital Management, LLC — — — — — — — — — — — 82.86K — — — —
Westchester Capital Management, LLC — — — — — — — — — — — 31.19K 31.19K — — —
HIGHBRIDGE CAPITAL MANAGEMENT LLC — — — — — — — — — — — — 54.18K — — —

下载持有人名单 (CSV)

常见问题

Which funds hold NAMSW?

As of 2026-Q3, 5 institutional funds reported holding NAMSW (NEWAMSTERDAM PHARMA COMPANY) in SEC 13F filings, with a combined reported value of $4.90M.

How many shares of NAMSW do institutions own?

13F filers reported 369.57K shares of NAMSW, worth $4.90M in aggregate at the end of 2026-Q3.

Is institutional ownership of NAMSW rising or falling?

Share counts moved +0.7% versus the prior quarter — accumulation.

Who are the top institutional holders of NAMSW?

The largest 13F holders are Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Millennium Management; the top 25 are ranked at the top of this page.

Who are the major shareholders of NEWAMSTERDAM PHARMA COMPANY?

The major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMSW) by reported 13F value are Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Millennium Management, among 24 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 NAMSW」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/NAMSW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →